Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease
about
Mini-review: Strategies for Variation and Evolution of Bacterial AntigensMonoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin DrugsMolecular basis of host specificity in human pathogenic bacteriaProteomics of Aggregatibacter actinomycetemcomitans Outer Membrane VesiclesThe Structure of Treponema pallidum Tp0751 (Pallilysin) Reveals a Non-canonical Lipocalin Fold That Mediates Adhesion to Extracellular Matrix Components and Interactions with Host Cells.Emerging experience with meningococcal serogroup B protein vaccines.Recent Progress in the Prevention of Serogroup B Meningococcal Disease.Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophagesHuman factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH bindingMeningococcal disease and the complement system.Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines.Progressive decrease in the potential usefulness of meningococcal serogroup B vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern SpainRecombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.In-silico prediction and deep-DNA sequencing validation indicate phase variation in 115 Neisseria meningitidis genes.Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore PersistenceThe biology of Neisseria adhesins.New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.Neisseria proteomics for antigen discovery and vaccine development.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.Antimicrobial peptide resistance in Neisseria meningitidis.Regulation of capsule in Neisseria meningitidis.In silico analysis and modeling of ACP-MIP-PilQ chimeric antigen from Neisseria meningitidis serogroup BVaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins.Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?The next chapter for group B meningococcal vaccines.Mycobacterium tuberculosis lipoproteins in virulence and immunity - fighting with a double-edged sword.Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.Insight into proteomic investigations of Neisseria meningitidis serogroup C strain L91543 from analysis of its genome sequence.Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria.Cross-protection induced by VA-MENGOC-BC® vaccine.Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.Bordetella pertussis isolates vary in their interactions with human complement components.Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementationPotential of the adhesin complex protein ofNeisseria meningitidisfor next-generation meningococcal vaccines
P2860
Q26796459-2D3662CD-C6EE-438E-8C80-6D66BA003F44Q26863621-1A0A3D88-081E-4773-8267-A8B4A66D4A31Q26864388-FCE8700C-5859-4B0C-89B3-6ED90514BF0EQ28548255-B1F876B3-A274-4FFC-B81B-ED9E4FCA02D4Q30152722-5E0AE64B-E41E-445A-9AE5-F8880B8C1743Q30234958-E9F79BE3-C300-43FB-AC01-D03D5BEECF14Q30235040-B1A0CAA2-A34E-43AF-8AE3-53C913AE26DEQ34075114-C67843A3-89BA-42F3-A8EA-B1B5DE4D88D5Q34237895-9EDBFFDF-952B-48BC-AF23-43A2277FAED6Q34376170-EB944D2A-6211-428E-9B94-2D69F606AA21Q34592926-57B78B43-B736-427F-AD23-B6391408AB95Q34776964-C8365133-3FED-4549-876E-2C4E28AC0F77Q34955474-74241D61-D503-45FA-AFF6-CE19B5D7A787Q35187629-14035C9B-3BEA-4E5F-8397-B2C2DDD8E590Q35922195-27F9CC7C-9200-4756-9FB1-A5752846764EQ36098758-89012C09-0C45-40E8-9031-14BC8A65120CQ36175206-4FC227B8-8E5D-4E9A-91A3-E24C9247937FQ36177419-6D43613E-EBDD-4F4B-801C-351960DD92D1Q37008156-C491C003-9E9E-442E-836D-50D71212CA9DQ37651436-41BA9D5E-4342-4DB2-8C28-E3E80AB72A06Q37690815-2EED015C-02AB-4918-A706-28DFEDDF578AQ38228941-FCAF1143-23D1-45B2-A601-3F236707FBA6Q38363907-172956DA-1E60-42A2-94AC-64424A0A802EQ38499031-DEC4A55E-0A89-4146-B5E3-0CD69F4D8615Q38531723-D7CB1DBC-EC44-4ECE-94D7-A8300A137FA1Q38534123-48BE146F-63FB-4943-A290-B9BF44A371DAQ38607614-D8543EC1-D53D-4EED-A299-9E2DA4463940Q38674983-654B992A-DF03-4853-9D4E-55B493DF3998Q38677309-7B5DD681-D3D3-43D6-A981-7F3E45AF7B6BQ38878969-95D1040A-E5BC-4EBE-B2E7-0F782C749390Q40207692-348EC507-D005-475C-B626-1C26ACEBFA27Q41110531-BA032C6E-08DF-45CC-B5B0-C2DB185C9EFEQ48090618-9666B842-A674-4670-95D6-6B300B69607DQ50116274-F6050AC9-EF2D-4192-9133-5BD756C45073Q52657380-7FBFE7D2-04B4-4BB9-A503-2612CCA44B61Q55003603-DCD7F994-860B-4F9E-911B-A1308A58ACEEQ58771225-3A46C45C-A8CF-47B2-A0D2-82372FAD497AQ58810801-90FE8F2E-2843-4B85-84DE-BA3B53F7B0D7
P2860
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Role of factor H binding prote ...... against meningococcal disease
@ast
Role of factor H binding prote ...... against meningococcal disease
@en
Role of factor H binding prote ...... against meningococcal disease
@nl
type
label
Role of factor H binding prote ...... against meningococcal disease
@ast
Role of factor H binding prote ...... against meningococcal disease
@en
Role of factor H binding prote ...... against meningococcal disease
@nl
prefLabel
Role of factor H binding prote ...... against meningococcal disease
@ast
Role of factor H binding prote ...... against meningococcal disease
@en
Role of factor H binding prote ...... against meningococcal disease
@nl
P2093
P2860
P3181
P356
P1476
Role of factor H binding prote ...... against meningococcal disease
@en
P2093
A. S. Anderson
G. W. Zlotnick
K. U. Jansen
L. K. McNeil
R. J. Zagursky
S. K. Hoiseth
P2860
P304
P3181
P356
10.1128/MMBR.00056-12
P407
P577
2013-06-01T00:00:00Z